Osborn Williams & Donohoe’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$6.25M Buy
30,808
+1,632
+6% +$356K 0.82% 37
2019
Q4
$7.03M Sell
29,176
-1,597
-5% -$352K 0.7% 45
2019
Q3
$5.96M Buy
30,773
+261
+0.9% +$50.1K 0.6% 49
2019
Q2
$5.62M Buy
30,512
+458
+2% +$82K 0.58% 47
2019
Q1
$5.77M Buy
30,054
+4,695
+19% +$897K 0.59% 46
2018
Q4
$4.94M Buy
25,359
+599
+2% +$117K 0.87% 35
2018
Q3
$5.13M Buy
24,760
+4
+0% +$788 0.8% 43
2018
Q2
$4.57M Buy
24,756
+322
+1% +$57K 0.77% 41
2018
Q1
$4.17M Buy
24,434
+119
+0.5% +$21.8K 0.72% 44
2017
Q4
$4.23M Sell
24,315
-196
-0.8% -$34.7K 0.72% 44
2017
Q3
$4.57M Buy
24,511
+54
+0.2% +$9.57K 0.82% 37
2017
Q2
$4.21M Sell
24,457
-283
-1% -$46K 0.76% 42
2017
Q1
$4.06M Sell
24,740
-220
-0.9% -$36.6K 0.73% 42
2016
Q4
$3.65M Buy
24,960
+3,322
+15% +$500K 0.69% 46
2016
Q3
$3.61M Sell
21,638
-1,515
-7% -$256K 0.69% 47
2016
Q2
$3.52M Buy
23,153
+292
+1% +$45.4K 0.68% 48
2016
Q1
$3.43M Buy
22,861
+6,341
+38% +$942K 0.69% 47
2015
Q4
$2.68M Buy
16,520
+665
+4% +$105K 0.55% 58
2015
Q3
$2.2M Buy
15,855
+756
+5% +$119K 0.48% 58
2015
Q2
$2.4M Buy
15,099
+477
+3% +$76.4K 0.48% 59
2015
Q1
$2.34M Buy
14,622
+1,425
+11% +$224K 0.45% 63
2014
Q4
$2.1M Buy
13,197
+972
+8% +$151K 0.41% 70
2014
Q3
$1.72M Buy
+12,225
New +$1.6M 0.36% 78

Other funds holding AMGN

Osborn Williams & Donohoe's AMGN Position: Q1 2020 in Review

Osborn Williams & Donohoe increased its Amgen (AMGN) stake by 5.6% in Q1 2020, buying an estimated $356K and bringing the position to 30,808 shares worth $6.25M. The position accounts for 0.82% of the portfolio, ranked #37.

Osborn Williams & Donohoe first reported a position in AMGN in Q3 2014 and has held it in 23 quarters since. The position peaked at $7.03M in Q4 2019. 2,029 funds tracked by Wall St. Rank hold AMGN as of Q1 2020.

  • Osborn Williams & Donohoe held 30,808 shares of Amgen worth $6.25M as of Q1 2020.
  • Osborn Williams & Donohoe bought 1,632 Amgen shares in Q1 2020, an estimated $356K.
  • Amgen made up 0.82% of Osborn Williams & Donohoe's portfolio in Q1 2020, its #37 holding.
  • Osborn Williams & Donohoe first reported a position in Amgen in Q3 2014 and has held it in 23 quarters since.
  • Osborn Williams & Donohoe's Amgen position peaked at $7.03M in Q4 2019.
  • 2,029 funds tracked by Wall St. Rank held Amgen as of Q1 2020.

Based on Osborn Williams & Donohoe's 13F filing for Q1 2020, filed 4 May 2020.